Search

everythinglearnresearchcommunity

for

Search:↓

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

PRP injections did not significantly improve hair growth in men with androgenetic alopecia.

PRP improves hair growth in AGA, but higher concentrations aren't significantly better than lower ones.

No single treatment is clearly effective for central serous chorioretinopathy.

Skin problems are very common in people with end-stage kidney disease.

Basal cell epithelioma resembles fetal hair follicles, not adult or fetal skin.

This document studied minoxidil in healthy volunteers. Minoxidil is quickly absorbed and eliminated from the body.

A man got unusual crescent-shaped cuts from a laser tattoo removal due to a laser technical issue, but healed without scars.

The document concludes that skin and nail changes can indicate various underlying health conditions.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

Nail and hair changes are common in severe chronic kidney disease and should be treated to improve patients' quality of life.

Finasteride tablets and capsules work the same in the body.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Half follicular grafts are not effective for hair transplants.

Half of hair restoration surgeons experience body discomfort, especially after follicular unit extraction procedures, and using ergonomic equipment or robotic devices could reduce this discomfort.

Half of the people with alcohol dependency in the study had liver disease and skin issues like seborrheic dermatitis, which are important signs of alcohol abuse.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.